share_log

Revelation Biosciences Q4 EPS $(8.33) Beats $(13.77) Estimate

Moomoo 24/7 ·  Mar 22 16:22

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(8.33) per share which beat the analyst consensus estimate of $(13.77) by 39.51 percent. This is a 84.31 percent increase over losses of $(53.10) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment